TY - JOUR
T1 - Modulators of 14-3-3 Protein-Protein Interactions
AU - Stevers, Loes M.
AU - Sijbesma, Eline
AU - Botta, Maurizio
AU - Mackintosh, Carol
AU - Obsil, Tomas
AU - Landrieu, Isabelle
AU - Cau, Ylenia
AU - Wilson, Andrew J.
AU - Karawajczyk, Anna
AU - Eickhoff, Jan
AU - Davis, Jeremy
AU - Hann, Michael
AU - O'Mahony, Gavin
AU - Doveston, Richard G.
AU - Brunsveld, Luc
AU - Ottmann, Christian
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2018/5/10
Y1 - 2018/5/10
N2 - Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein-protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as "undruggable" targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.
AB - Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein-protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as "undruggable" targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.
UR - http://www.scopus.com/inward/record.url?scp=85034254360&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.7b00574
DO - 10.1021/acs.jmedchem.7b00574
M3 - Article
C2 - 28968506
AN - SCOPUS:85034254360
SN - 0022-2623
VL - 61
SP - 3755
EP - 3778
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 9
ER -